Picard Medical, Inc. (PMI) EBITDA
- 2026-06-30: Basis Reported; EBITDA -$4.58M*; Operating income -$4.63M; Depreciation and amortization $45.00K*.
- 2026-03-31: Basis Reported; EBITDA -$4.47M; Operating income (m); Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA -$2.96M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA -$3.45M*; Operating income -$3.49M; Depreciation and amortization $41.00K*.
Complete source-backed ebitda history.
- Available history
- 2024-12-31 to 2026-03-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | -$4.58M* | -$4.63M | $45.00K* | $2.95M | -155.18%* | $0.00* | -$1.35M* | (m) | $1.37M | $3.87M | $7.00K |
|---|
| 2026-03-31 | Reported | -$4.47M | (m) | (m) | (m) | -388.26% | $26.00K | -$3.80M | (m) | $1.90M | $2.89M | $0.00 |
|---|
| 2025-12-31 | Reported | -$2.96M | (m) | (m) | (m) | -293.66% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2025-09-30 | Reported | -$3.45M* | -$3.49M | $41.00K* | $1.19M | -290.31%* | (m) | -$6.51M* | (m) | $951.00K | $2.41M | $0.00 |
|---|
| 2025-06-30 | Reported | -$3.48M* | -$3.52M | $40.00K* | $2.13M | -163.35%* | $0.00* | -$2.54M* | (m) | $743.00K | $2.65M | $0.00 |
|---|
| 2025-03-31 | Reported | -$3.2M | (m) | (m) | (m) | -516.77% | $0.00 | -$2.24M | (m) | $808.00K | $2.08M | $31.00K |
|---|
| 2024-12-31 | Reported | -$3.53M | (m) | (m) | (m) | -422.25% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2024-09-30 | Reported | (m) | -$4.44M | (m) | $881.00K | (m) | (m) | -$2.61M* | (m) | $961.00K | $2.81M | $0.00 |
|---|
| 2024-06-30 | Reported | (m) | -$3.82M | (m) | (m) | (m) | (m) | (m) | (m) | $940.00K | $2.50M | (m) |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | -$13.09M | (m) | (m) | (m) | -265.06% | (m) | -$15.67M | (m) | $3.05M | $10.00M | $35.00K |
|---|
| 2024-12-31 | Reported | -$13.49M | (m) | (m) | (m) | -307.13% | (m) | -$11.87M | (m) | $3.38M | $10.22M | -$15.00K |
|---|